Tom Taulli

Tom Taulli

InvestorPlace Contributor

Expertise: Artificial intelligence, cloud computing, cybersecurity

Education: BA, Cal Poly Pomona; JD, Whittier Law School

Awards & Accomplishments: IRS Enrolled Agent; California insurance license

Tom Taulli is the author of various books. They include Artificial Intelligence Basics and the Robotic Process Automation Handbook. His upcoming book is called Generative AI: How ChatGPT and other AI Tools Will Revolutionize Business.

Besides his writing, Tom has authored courses for PluralSight, Apress and O’Reilly Publishing. And yes, they are about topics like AI and cloud computing.

Tom currently advises various early stage companies about AI. He also is an angel investor.

Before this, Tom founded tech companies like ExamWeb, WebIPO and Hypermart, which was sold to InfoSpace.

Recent Articles

7 Internet Stocks to Watch

By Tom Taulli, InvestorPlace Contributor

In the UK, it looks like the government will impose stricter regulations on the internet, but this isn't a signal to unload internet stocks.

Pinterest IPO: What Can We Expect As Another Unicorn Comes To Market?

By Tom Taulli, InvestorPlace Contributor

Pinterest plans to come public next week. The company is solid , but investors should still treat this deal as a high-risk proposition.

3 Reasons Booking Holdings Stock Will Take Flight

By Tom Taulli, InvestorPlace Contributor

Booking Holdings stock has been a laggard over the past year. But this could be setting up for a value opportunity. Here's a look at 3 key bullish factors.

CVS Stock Is Not Nearly as Cheap as You Might Think

By Tom Taulli, InvestorPlace Contributor

CVS stock has been mostly a losing proposition for investors since 2015. So maybe now -- with the valuation fairly low -- is a good time for a purchase? Well, investors may still want to wait.

Cronos Group: 3 Pros, 3 Cons for Buying CRON Stock on This Dip

By Tom Taulli, InvestorPlace Contributor

Cronos Group is one of the top operators in the fast-growing cannabis market, but CRON stock has leveled off lately as Wall Street gets anxious. What now?

Load More